Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to OCTRU's Katie Chegwin who has been awarded the Oxfordshire Apprentice of the Year and Higher Apprentice Awards in the Oxfordshire Apprenticeship Awards 2018!

Katie Chegwin collecting her award for Oxfordshire Apprentice of the Year

Katie was nominated for these awards for being ‘incredibly driven throughout her apprenticeship programme, exceeding requirements and timely achieve success at every given opportunity’.

Her tremendous achievements stood out and were recognised by the judging panel this week, at the awards ceremony held at Blenheim Palace. Katie brought home not just one but two awards, as she won the Oxfordshire Apprentice of the Year Award as well.

For anybody thinking about jumping onto the scheme I would say do it!- Katie Chegwin

Katie joined NDORMS in October 2015 as its’ first apprentice, and following on there are now further apprentices within the department working with different groups and teams. Working within the Oxford Clinical Trials Research Unit (OCTRU) and now also in the Centre for Statistics in Medicine (CSM), Katie has been undertaking training in clinical trials whilst also undertaking her NVQ 3 and now NVQ 4 in Business Administration. 

Katie said on receiving the award: “I could not feel happier to have been awarded with the title of Oxfordshire’s Higher Apprentice of the Year and Higher Apprentice of the Year. From being shortlisted for the award and having an interview with Nielsen to the evening at Blenheim Palace, both of which were fantastic experiences which I will never forget!

Since starting my apprenticeship, I could not have imagined all of the personal and professional growth that I would experience. I have turned my weaknesses into strengths which subsequently has enabled my confidence to shine through. 

I am very grateful for everyone’s support and I would like to say a huge thank you to my employers for giving me this opportunity as well as my family and friends who have been so supportive. I believe the awards are a true reflection of how great my apprenticeship has been and for anybody thinking about jumping onto the scheme I would say do it!"

Emma Haines, Katie's supervisor at OCTRU says: "I am so pleased that Katie has won this award, she is incredibly focused, committed and motivated to achieve her level 4 diploma. She has exceeded requirements at every opportunity and her friendly and helpful personality has made it a pleasure to support her in her apprenticeship. Katie is a highly valued member of our team and has been a great example of how effective apprenticeships can be for both employer and learner."

Katie Chegwin Apprentice of the Year Awards

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.